Asymmetric porous hydrogel with anti-deformation, anti-adhesion and healing-promoting properties and preparation method thereof

The asymmetric porous hydrogel addresses foreign body reactions and adhesions by utilizing a solvent conversion method to create a patch with anti-deformation and healing-promoting properties, ensuring effective soft tissue repair.

CN114907582BActive Publication Date: 2024-12-06THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210517710.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-12-22
Filing Date
2022-05-12
Publication Date
2024-12-06
Estimated Expiration
2042-05-12

AI Technical Summary

Technical Problem

Existing synthetic patches for soft tissue defects cause foreign body reactions and visceral adhesions, and lack micro-nano structures similar to the extracellular matrix, leading to poor wound healing and deformation.

Method used

A bio-friendly asymmetric porous hydrogel is constructed using a solvent conversion method, involving PVA dissolution in DMSO, solvent exchange, freeze-drying, and rehydration, creating a loose extracellular matrix-like surface for fibroblast adhesion and a dense surface for adhesion prevention.

Benefits of technology

The hydrogel provides long-term tension-free repair with anti-swelling and high mechanical properties, preventing visceral adhesions and promoting tissue healing by enhancing fibroblast adhesion and proliferation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114907582B_ABST
    Figure CN114907582B_ABST
Patent Text Reader

Abstract

The present invention relates to an asymmetric porous hydrogel having anti-deformation, anti-adhesion and healing-promoting properties and a preparation method thereof. Polyvinyl alcohol is dissolved in dimethyl sulfoxide, and then solvent exchange is performed in deionized water; the obtained polyvinyl alcohol solvent exchange gel is freeze-dried and rehydrated to prepare an asymmetric porous hydrogel. The asymmetric porous hydrogel prepared by the solvent exchange method of the present invention has unique anti-swelling properties and high mechanical properties, and can achieve long-term tension-free repair in vivo. More importantly, the upper and lower surfaces of the asymmetric porous hydrogel prepared by the present invention have completely opposite cell adhesion behaviors. The loose extracellular matrix-like porous upper surface can promote fibroblast adhesion and proliferation. On the contrary, the dense lower surface has almost no cell adhesion; thereby achieving the functions of promoting tissue healing and preventing adhesion (adhesion score = 0) at the same time, and realizing efficient repair of soft tissue defects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of surgical biomedical materials, and more specifically, to an asymmetric porous hydrogel having anti-deformation, anti-adhesion and healing-promoting properties and a preparation method thereof. Background Art

[0002] At present, soft tissue defects in the body are often caused by surgical trauma, primary or secondary tumor resection, trauma, severe infection, etc., and can be seen in multiple parts such as the abdominal wall, chest wall and dura mater, resulting in at least 400,000 surgeries and annual medical expenses of up to 10 billion US dollars worldwide. Soft tissue defects in the body often include defects in the peritoneum and muscle layer. The loss of the serosal membrane increases the risk of visceral adhesions, and defects in the muscle layer often cause high-tension closure by simple suturing. These two problems pose great challenges to surgical operations. In recent years, tension-free repair surgery using patches has been recommended as the standard treatment for soft tissue defects.

[0003] Traditional high-strength, deformation-resistant synthetic patches (such as polypropylene and polyester patches) have been widely used in tension-free repair surgery for soft tissue defects. However, these mesh patches are prone to cause significant foreign body reactions, which may lead to severe visceral adhesions and poor wound healing. In recent years, covering the surface of polypropylene and polyester patches with anti-adhesion coatings has become the most common method to deal with visceral adhesions. For example, PCO patches significantly reduce the occurrence of visceral adhesions by coating an anti-adhesion collagen layer on a polyester mesh. However, these polypropylene and polyester-based composite meshes have severe foreign body reactions and lack micro-nano structures similar to extracellular matrix. In addition, the collagen coating will swell highly in the body, significantly increasing the risk of deformation of the composite mesh. At present, there is no ideal patch that can simultaneously deal with visceral adhesions and soft tissue defect repair problems. Summary of the invention

[0004] The present invention aims to overcome at least one of the shortcomings of the above-mentioned prior art and provide an asymmetric porous hydrogel having anti-deformation, anti-adhesion and healing-promoting properties and a preparation method thereof. The present invention obtains a bio-friendly asymmetric porous hydrogel by constructing a new strategy based on solvent conversion. As a patch, the asymmetric porous hydrogel can achieve at least the following effects during the whole process of efficiently repairing soft tissue defects in vivo: (1) long-term tension-free repair without obvious foreign body reaction; (2) long-term prevention of visceral adhesion; (3) effective promotion of the healing of soft tissue defects.

[0005] Another object of the present invention is to provide the hydrogel to achieve the function of maintaining anti-deformation in a wet environment in vivo through the properties of anti-swelling and high mechanical properties.

[0006] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving polyvinyl alcohol (PVA) in dimethyl sulfoxide (DMSO); (2) pouring the PVA / DMSO solution of step (1) into a mold, and immersing the mold in water for solvent exchange to obtain an asymmetric PVA solvent exchange gel; (3) freeze-drying the asymmetric PVA solvent exchange gel obtained in step (2) to obtain an asymmetric PVA cryogel; (4) immersing the asymmetric PVA cryogel obtained in step (3) in water, rehydrating, and obtaining an asymmetric porous PVA hydrogel with anti-deformation, anti-adhesion and healing-promoting properties. Wherein, the PVA / DMSO solution is a DMSO solution of PVA. Specifically, the hydrogel with an asymmetric porous structure obtained in step (4) is recorded as JPVA hydrogel; the asymmetric PVA solvent exchange gel obtained in the aforementioned step (1) is recorded as JPVA solvent exchange gel; and the asymmetric PVA cryogel obtained in the aforementioned step (3) is recorded as JPVA cryogel.

[0007] The present application successfully prepared a JPVA hydrogel with an asymmetric porous structure by using a top-down solvent exchange strategy, freeze drying, and rehydration in a PBS solution. PVA was dissolved in DMSO under heating and mechanical stirring to form a uniform high-viscosity solution. After cooling to room temperature, the DMSO solution of PVA was poured into a mold and then immersed in deionized water. Due to the unique amphiphilicity of PVA, water transforms polyvinyl alcohol (PVA) from a solution to a gel by forming hydrogen bonds during the top-down solvent exchange process. That is, deionized water acts as a poor solvent for PVA during solvent exchange, causing PVA to undergo hydrogen bond crosslinking and gelation; at the same time, a small portion of the PVA chains on the top surface of the gel can be dissolved in water together with DMSO, ultimately resulting in a looser porous morphology on the top surface of the JPVA hydrogel, thereby ultimately forming an asymmetric surface structure of the gel. The loose extracellular matrix-like porous top surface is conducive to fibroblast adhesion and soft tissue growth, while the dense porous bottom surface can completely prevent visceral adhesion in the abdominal wall defect repair model, thereby achieving both healing promotion and anti-adhesion functions.

[0008] Preferably, the specific operation of step (1) is: adding PVA to DMSO under heating in an oil bath at 60° C. and stirring for 2 h until it is completely dissolved. This operation is also performed in the embodiments of the present invention.

[0009] Furthermore, in the PVA / DMSO solution, the mass percentage concentration of PVA is 5wt%-30wt%.

[0010] Preferably, the PVA degree of polymerization ranges from 100 to 4500, and the alcoholysis degree ranges from 88% to 99%. More preferably, the PVA degree of polymerization ranges from 1700 to 4500, and the alcoholysis degree ranges from 97% to 99%. Within this range, a better asymmetric porous hydrogel can be obtained.

[0011] Preferably, the PVA has a degree of polymerization of 1700 and a degree of alcoholysis of 99%.

[0012] Preferably, the PVA model is PVA-1799.

[0013] Within a certain range, as the degree of polymerization of PVA increases, the solubility of PVA in DMSO and water decreases, the viscosity of the PVA / DMSO solution increases, and the mechanical properties of the JPVA solvent exchange gel obtained subsequently increase. Similarly, as the degree of alcoholysis of PVA increases, the solubility of PVA in DMSO and water decreases, the viscosity of the PVA / DMSO solution increases, and the mechanical properties of the JPVA solvent exchange gel obtained subsequently increase. Considering the difficulty of operation and cost, the preferred PVA model used in the present invention is PVA-1799.

[0014] Preferably, the specific operation of step (2) is: the PVA / DMSO solution is quickly poured into the mold and spread flat, and immersed in constant temperature water (deionized water) for solvent exchange.

[0015] Preferably, the thickness of the PVA / DMSO solution is 1-5 mm. More preferably, in one or more embodiments of the present invention, the mold is 3.5-5 cm long and 2-3.5 cm wide, and the thickness of the PVA / DMSO solution is 1-5 mm.

[0016] Preferably, the water temperature for solvent exchange is 4-40° C., and the solvent exchange time is not less than 2 h.

[0017] Preferably, the water used for solvent exchange is replaced every 8 hours.

[0018] Preferably, the solvent exchange time is 48 h.

[0019] Within a certain range, as the water temperature of the solvent exchange increases, the solvent exchange rate becomes faster, while the thickness of the JPVA solvent exchange gel obtained subsequently decreases, and the pore size of the asymmetric porous cryogel obtained subsequently increases; when the temperature is too high, PVA will dissolve in the water and cannot effectively form a gel. On the other hand, as the frequency of water replacement for solvent exchange increases, or the time of solvent exchange increases, the amount of residual DMSO in the resulting JPVA solvent exchange gel becomes less. Considering the time cost of the comprehensive production process, the present invention preferably replaces the water used for solvent exchange every 8 hours, and the solvent exchange time is 48 hours.

[0020] Preferably, the specific operation of step (3) is as follows: after the JPVA solvent exchange gel is completely frozen in liquid nitrogen, it is quickly transferred to a freeze dryer for freeze drying until it is completely dry.

[0021] Preferably, the specific operation of step (4) is: the JPVA cryogel obtained in step (3) is rehydrated in an aqueous solution.

[0022] Preferably, in step (4), the aqueous solution is any one of deionized water, physiological saline or PBS buffer solution.

[0023] Preferably, in step (4), the aqueous solution is a PBS buffer solution.

[0024] Preferably, in step (4), the aqueous solution is a 0.01 M PBS buffer solution.

[0025] During the rehydration process, the aqueous solution used is close to the physiological state, and the obtained JPVA hydrogel is more conducive to cell and tissue growth. Therefore, the aqueous solution preferably used for rehydration in the present invention is 0.01M PBS buffer solution.

[0026] Another object of the present invention is to provide an asymmetric porous hydrogel obtained by the above preparation method.

[0027] Another object of the present invention is to provide an application of the asymmetric porous hydrogel in the preparation of tissue defect patches, wherein the soft tissue defect patches include abdominal wall defects, chest wall defects, dura mater defects, visceral defects and the like.

[0028] Another object of the present invention is to provide a soft tissue defect patch, comprising the above-mentioned asymmetric porous hydrogel. The soft tissue defect patch provided by the present invention is an asymmetric porous hydrogel patch inspired by peritoneum and has anti-deformation, anti-adhesion and healing-promoting properties.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] (1) The present invention provides a method for preparing a bio-friendly asymmetric porous hydrogel. The asymmetric porous hydrogel constructed by the combined strategy of "solvent exchange-freeze drying-rehydration" has unique anti-swelling properties and stable high mechanical properties, and can resist deformation in a wet environment in vivo for a long time. The method is simple, efficient and green;

[0031] (2) Another object of the present invention is to provide a hydrogel having an asymmetric porous structure, which utilizes the asymmetric porous structure to simultaneously achieve the functions of preventing visceral adhesion and promoting tissue defect healing, thereby promoting the efficient repair of soft tissue defects in vivo;

[0032] (3) More importantly, the asymmetric porous hydrogel surface prepared by the present invention has completely opposite cell adhesion behaviors. The loose extracellular matrix-like porous upper surface can promote fibroblast adhesion and proliferation, while the dense lower surface has almost no cell adhesion. Thus, it can simultaneously achieve the functions of promoting tissue healing and preventing adhesion (adhesion score = 0), and can efficiently repair soft tissue defects. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] Figure 1 This is a physical picture of the JPVA hydrogel of Example 1;

[0034] Figure 2 1 is a SEM image of the upper and lower surfaces of the JPVA cryogel of Example 1;

[0035] Figure 3 This is a digital photograph of the JPVA hydrogel of Example 1 sutured on pig muscle;

[0036] Figure 4 JPVA solvent exchange gel, JPVA hydrogel and JPVA-14d, which are tensile stress-strain curves of Example 1;

[0037] Figure 5 is the swelling ratio of the JPVA hydrogel of Example 1;

[0038] Figure 6 This is a CCK-8 assay diagram of the JPVA hydrogel of Example 1;

[0039] Figure 7-8 The adhesion formation photos and adhesion score quantitative analysis of the PP patch, PCO patch and JPVA hydrogel of Example 1 on the 14th day after the repair of abdominal wall defects in rats;

[0040] Fig. 9 The histomorphological evaluation of wound healing tissue 14 days after surgery for repairing abdominal wall defects with PP patch, PCO patch and JPVA hydrogel of Example 1 included HE staining images, CD68 immunohistochemical staining images, Masson staining images, and quantitative analysis of wound CD68 and collagen density. DETAILED DESCRIPTION

[0041] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.

[0042] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0043] The present invention is now further described in conjunction with specific examples. The following examples are only for explaining the present invention, but do not constitute a limitation of the present invention. The test samples and test processes used in the following examples include the following (if the specific experimental conditions are not indicated in the examples, they are usually in accordance with conventional conditions or the conditions recommended by the reagent company; the reagents, consumables, etc. used in the following examples, if not otherwise specified, can all be obtained from commercial channels).

[0044] Example 1

[0045] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 1.8g of polyvinyl alcohol (PVA-1799) in 10mL of dimethyl sulfoxide (DMSO); (2) pouring the PVA / DMSO solution of step (1) into a mold, the solution thickness is 1-5mm, and immersing it in 20°C deionized water for solvent exchange for 48 hours, changing the water every 8 hours to obtain a JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a JPVA cryogel; (4) immersing the JPVA cryogel obtained in step (3) in a 0.01M PBS buffer solution for rehydration to obtain an asymmetric porous JPVA hydrogel soft tissue defect patch. And the asymmetric porous JPVA hydrogel prepared in Example 1 is used as a soft tissue defect patch as the experimental object of the following effect examples.

[0046] Specifically, the material sources in this embodiment include: polyvinyl alcohol 1799 (PVA-1799, alcoholysis degree 98-99 mol%, water content ≈ 1.4 wt%), dimethyl sulfoxide (DMSO) and PBS buffer (0.01 mol L -1 , pH 7.4) was purchased from Macklin. Cell Counting Kit-8 (CCK-8) and Calcein AM / PI double staining kit were purchased from Beijing Solebio Biotechnology Co., Ltd. (Beijing, China). All solvents and chemicals were purchased from commercial sources and used without further purification. Similarly, the materials in the following examples were also purchased from commercial sources.

[0047] Example 2

[0048] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 0.9g PVA-1799 in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing it in deionized water at 20°C for solvent exchange for 48 hours, changing the water every 8 hours, and obtaining a solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a frozen gel; (4) immersing the JPVA frozen gel obtained in step (3) in water, rehydrating it, and obtaining a JPVA hydrogel soft tissue defect patch.

[0049] Example 3

[0050] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 0.5g PVA-1799 in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing it in deionized water at 4°C for solvent exchange for 48 hours, changing the water every 8 hours, and obtaining a JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a frozen gel; (4) immersing the JPVA frozen gel obtained in step (3) in water, rehydrating it, and obtaining a JPVA hydrogel soft tissue defect patch.

[0051] Example 4

[0052] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 3.0g PVA-1799 in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing it in 40°C deionized water for solvent exchange for 48 hours, changing the water every 8 hours, to obtain a JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a frozen gel; (4) immersing the JPVA frozen gel obtained in step (3) in water, rehydrating it, to obtain a JPVA hydrogel soft tissue defect patch.

[0053] Example 5

[0054] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 1.8g PVA-1788 in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing it in deionized water at 20°C for solvent exchange for 48 hours, changing the water every 8 hours, to obtain a JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a frozen gel; (4) immersing the JPVA frozen gel obtained in step (3) in water, rehydrating it, and obtaining a JPVA hydrogel soft tissue defect patch.

[0055] Example 6

[0056] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 1.8g PVA-2099 (polymerization degree 2000, alcoholysis degree 99%) in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing in deionized water at room temperature for solvent exchange for 48 hours, changing the water every 8 hours, to obtain a JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a cryogel; (4) immersing the JPVA cryogel obtained in step (3) in physiological saline for rehydration to obtain a JPVA hydrogel soft tissue defect patch.

[0057] Example 7

[0058] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 1.8g PVA-262 (polymerization degree 62, alcoholysis degree 88%) in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing in deionized water at room temperature for solvent exchange for 48 hours, changing the water every 8 hours, to obtain a JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a frozen gel; (4) immersing the JPVA frozen gel obtained in step (3) in deionized water, rehydrating, to obtain a JPVA hydrogel soft tissue defect patch.

[0059] Example 8

[0060] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present invention is: a method based on solvent conversion to construct a bio-friendly asymmetric porous hydrogel, comprising the following steps: (1) dissolving 1.8g PVA (polymerization degree 4500, alcoholysis degree 88%) in 10mL DMSO; (2) pouring the PVA / DMSO solution of step (1) into a mold with a solution thickness of 1 to 5mm, immersing in deionized water at 39°C for solvent exchange for 48 hours, changing the water every 8 hours, to obtain JPVA solvent exchange gel; (3) freeze-drying the JPVA solvent exchange gel obtained in step (2) to obtain a frozen gel; (4) immersing the JPVA frozen gel obtained in step (3) in deionized water, rehydrating, to obtain a JPVA hydrogel soft tissue defect patch.

[0061] Effect Example 1

[0062] In this effect example, the surface morphology of the JPVA cryogel prepared in Example 1 was observed using a cold field emission scanning electron microscope (SEM). Figure 2 As shown: During the top-down solvent exchange process, a small amount of low molecular weight PVA (mass loss rate ≈ 4.6%) will dissolve into water together with DMSO, resulting in a low solid content on the upper surface, forming a loose, porous and rough upper surface morphology after freeze-drying; the pore size range of the upper surface of JPVA cryogel is 0.77-2.15μm. In contrast, the lower surface of JPVA cryogel presents a dense porous structure with a pore size range of 0.11-0.51μm.

[0063] Effect Example 2

[0064] In this study, a universal mechanical testing machine (WD-5A, Guangzhou Experimental Instrument Factory, China) was used to perform tensile tests to characterize the mechanical properties of the samples. The samples were cut into dumbbell-shaped blocks (4 mm wide) and the tensile speed was set to 30 mm min -1 The results are as follows Figure 4 As shown: the tensile strength of JPVA solvent exchange gel is 0.5MPa, and the initial tensile strength of JPVA hydrogel is 1.3MPa; interestingly, unlike the large amount of hydrogels that show inevitable high swelling and mechanical weakening in a humid environment, the tensile strength of JPVA hydrogels soaked in PBS buffer for 14 days (denoted as JPVA-14d hydrogel) is higher than that of unsoaked JPVA hydrogels (1.7MPa>1.3MPa). These results show that JPVA hydrogels with excellent anti-deformation properties can achieve long-lasting tension-free repair.

[0065] Effect Example 3

[0066] This effect example uses the weighing method to measure the swelling rate. The weight of the JPVA hydrogel is first measured as w 0The hydrogel sample was then immersed in PBS buffer (pH 7.4) at 37°C and shaken at 120 rpm. After a predetermined time, the sample was taken out and its weight was w t The swelling ratio Δw is calculated according to equation (1):

[0067]

[0068] The results are as follows Figure 5 As shown: The swelling rates of JPVA hydrogel after immersion in PBS buffer for 1, 3, 7 and 14 days were 5.9%, 6.4%, 5.5% and 5.3%, respectively, which were significantly lower than most of the reported anti-adhesion hydrogels.

[0069] Effect Example 4

[0070] In this study, CCK 8 was used to test the cytotoxicity of JPVA hydrogel. Figure 6 As shown: Compared with the control group, there was no significant difference in the proliferation of L929 fibroblasts in the JPVA hydrogel group on days 1, 2, and 3, demonstrating that JPVA hydrogel has good biocompatibility.

[0071] Effect Example 5

[0072] This study evaluated the effect of JPVA hydrogel in preventing adhesion and promoting defect healing by repairing the abdominal wall defect model of Sprague-Dawley rats. Figure 7-8 As shown in the figure, the PP mesh patch caused severe visceral adhesion formation, with a clinical adhesion score of 9.8 points; in sharp contrast, the JPVA hydrogel of the present application did not cause any visceral adhesion formation, with a clinical adhesion score of 0 points, and the anti-adhesion effect was similar to that of the PCO mesh patch. Fig. 9 As shown: Compared with PP and PCO patches, the healing tissue of abdominal defects repaired by JPVA hydrogel has lower inflammatory cell infiltration, higher collagen fiber deposition, and better healing effect.

[0073] Obviously, the above embodiments of the present invention are merely examples for clearly illustrating the technical solution of the present invention, and are not intended to limit the specific implementation methods of the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the claims of the present invention shall be included in the protection scope of the claims of the present invention.

Claims

1. A method for preparing an asymmetric porous hydrogel with anti-deformation, anti-adhesion and healing-promoting properties, It is characterized in that Includes steps: (1) dissolving polyvinyl alcohol (PVA) in dimethyl sulfoxide (DMSO); (2) pouring the PVA / DMSO solution obtained in step (1) into a mold and immersing it in water for solvent exchange to obtain an asymmetric PVA solvent exchange gel; (3) freeze-drying the asymmetric PVA solvent exchange gel obtained in step (2) to obtain an asymmetric PVA cryogel; (4) rehydrating the asymmetric PVA cryogel obtained in step (3) to obtain an asymmetric porous hydrogel having anti-deformation, anti-adhesion and healing-promoting properties; The top surface of the asymmetric porous hydrogel is in a loose porous form, and the bottom surface is in a dense porous form; The solvent exchange temperature in the solvent exchange process of step (2) is 4-40° C., and the solvent exchange time is not less than 2 h; The degree of polymerization of PVA ranges from 100 to 4500, and the degree of alcoholysis ranges from 88% to 99%.

2. The preparation method according to claim 1, It is characterized in that In step (1), in the PVA / DMSO solution, the mass percentage concentration of PVA is 5wt% to 30wt%.

3. The preparation method according to claim 1, It is characterized in that In step (4), the rehydration liquid is an aqueous solution.

4. The preparation method according to claim 3, It is characterized in that The aqueous solution includes water, deionized water, physiological saline or PBS buffer solution.

5. The preparation method according to claim 1, It is characterized in that The degree of polymerization of PVA is 1700 and the degree of alcoholysis is 99%.

6. An asymmetric porous hydrogel obtained by the preparation method according to any one of claims 1 to 5.

7. Use of the asymmetric porous hydrogel as claimed in claim 6 in preparing a soft tissue defect patch.

8. A soft tissue defect patch, It is characterized in that Comprising the asymmetric porous hydrogel according to claim 6.